IFNG and schizophrenia: Previous work from our group demonstrated that transient IFNγ treatment (24 hr) of hiPSC-NPCs from healthy controls increases neurite outgrowth (a cellular phenotype associated with neurodevelopmental disorders) and disproportionately alters the expression of genes associated with schizophrenia and autism (Warre-Cornish et al., 2020).